MAPT and Alzheimer disease: In AD, gut dysbiosis alters patterns of SCFA production, typically leading to decreased butyrate-producing taxa, such as Faecalibacterium prausnitzii, and increased acetate concentrations, which correlate with β-amyloid (Aβ) aggregation and tau hyperphosphorylation [70, 71].